Bozkurt, CeyhunAksoy, B.Aydoğdu, S.Bozkurt, SüreyyaErol Çipe, FundaÖner, O.Özsoy, S.Fışgın, T.2020-12-082020-12-0820201545-50091545-5017https://hdl.handle.net/20.500.12713/1268: Allogeneic stem cell transplantation in patients with a diagnosis of high-risk acute lymphoblastic leukemia results in high rates of survival in developed countries. Our aim with this presentation was to share our center’s experience on this subject. Methods: Hematopoietic stem cell transplantation was performed in a total of 69 patients with a diagnosis of high-risk acute lymphoblastic leukemia between 2015 and 2020 at our center. The demographic and treatment-related information of the patients was retrospectively evaluated.eninfo:eu-repo/semantics/closedAccessOncologyHematologyPediatricsOncologyHematologyPediatricsConference Object67Supplement: 4S481S481WOS:000581769201452Q1